Any peptide reconstituted with sterile water should be used within 24 hours, even when refrigerated
Injectable forms are not FDA-approved and should be avoided
Special population studies Investigating cagrilintide in populations with specific metabolic conditions, different ethnic backgrounds, and varying baseline characteristics
Each batch undergoes comprehensive testing for heavy metals, microbial contamination, and endotoxins through third-party laboratories including SGS, providing documentation that supports regulatory submissions in markets including North America, Europe, Switzerland, South Africa, Southeast Asia, and Australia
Reconstituted peptides should be colorless to very slightly yellow
For current information on peptide availability and regulatory changes, see our FDA peptide crackdown 2026 analysis